Vaxart, Inc.
SAN FRANCISCO, CA · CIK 0001480950 · Biotech · Private
Oral recombinant pill vaccines using a proprietary delivery platform
vaxart.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $23M
- 2 Form D · Aug 2013
- 158 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 28
- 2 granted · 26 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓200920102011201220132014
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $3,496,108 | |
| Private capital raised | Form D · SEC | $19,999,997 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2464 | Pharmazz, Inc. | — | $25M |
| 2465 | Abzena plc | — | $4.3M |
| 2466 | CURADEL SURGICAL INNOVATIONS, INC. | — | $24M |
| 2467 | Vaxart, Inc. | — | $23M |
| 2468 | PULMOTECT, INC | — | $22M |
| 2469 | New Echota Biotechnology | — | — |
| 2470 | Rocket Pharmaceuticals Ltd. | — | $28M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- John CornwellExecutive Officer
- Michael FinneyDirector · Executive Officer
- Wouter LatourDirector · Executive Officer
- Jan LeschlyDirector
- David LiebowitzExecutive Officer
- David MaddenExecutive Officer
- Richard MarkhamDirector
- Sean TuckerDirector · Executive Officer
Patents
- Formulations For Small Intestinal Delivery Of Rsv And Norovirus Antigensapplication
- Formulations For Small Intestinal Deliveryapplication
- Formulations For Small Intestinal Delivery Of Rsv And Norovirus Antigensgranted
- Chimeric Adenoviral Vectorsapplication
- Chimeric Adenoviral Vectorsapplication
- Formulations For Small Intestinal Delivery Of Rsv And Norovirus Antigensgranted
- Anhydrous Crystalline Free Base Form Of 6-{2-[1-(6-METHYL-3-PYRIDAZINYL)-4-PIPERIDINYL]ETHOXY}-3-ETHOXY-1,2-BENZISOXAZOLEapplication
- Hsv Vaccinesapplication
- Formulations For Small Intestinal Deliveryapplication
- Chimeric Adenoviral Vectorsapplication
- Chimeric Adenoviral Vectorsapplication
- Heterocyclic Derivatives For The Thratment Of Rsvapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.